2025-11-01 2026-10-31 2026-10-31 false 11616836 Ameira Therapies Ltd 86900Other human health activities iso4217:GBP xbrli:pure 116168362025-11-01 116168362026-10-31 116168362025-11-01 2026-10-31 11616836bus:Micro-entities2025-11-01 2026-10-31 11616836bus:AuditExempt-NoAccountantsReport2025-11-01 2026-10-31 11616836bus:FullAccounts2025-11-01 2026-10-31 11616836core:WithinOneYear2026-10-31 11616836core:AfterOneYear2026-10-31 11616836core:WithinOneYear2025-11-01 2026-10-31 11616836core:AfterOneYear2025-11-01 2026-10-31 11616836core:CurrentFinancialInstruments2026-10-31 11616836core:Non-currentFinancialInstruments2026-10-31 11616836core:CurrentFinancialInstruments2025-11-01 2026-10-31 11616836core:Non-currentFinancialInstruments2025-11-01 2026-10-31 11616836core:LandBuildings2025-11-01 2026-10-31 11616836core:FurnitureFittings2025-11-01 2026-10-31 11616836core:OfficeEquipment2025-11-01 2026-10-31 11616836core:Vehicles2025-11-01 2026-10-31 11616836core:PlantMachinery2025-11-01 2026-10-31 11616836core:OtherPropertyPlantEquipment2025-11-01 2026-10-31 11616836core:LandBuildings2026-10-31 11616836core:PlantMachinery2026-10-31 11616836core:Vehicles2026-10-31 11616836core:FurnitureFittings2026-10-31 11616836core:OfficeEquipment2026-10-31 11616836core:OtherPropertyPlantEquipment2026-10-31 11616836core:Right-of-useAssets2025-11-01 2026-10-31 11616836core:Right-of-useAssets2026-10-31 11616836core:Goodwill2025-11-01 2026-10-31 11616836core:PatentsTrademarksLicencesConcessionsSimilar2025-11-01 2026-10-31 11616836core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-11-01 2026-10-31 11616836core:OtherResidualIntangibleAssets2025-11-01 2026-10-31 11616836core:Goodwill2026-10-31 11616836core:DevelopmentCostsCapitalisedDevelopmentExpenditure2026-10-31 11616836core:PatentsTrademarksLicencesConcessionsSimilar2026-10-31 11616836core:OtherResidualIntangibleAssets2026-10-31 11616836dpl:CostSales2025-11-01 2026-10-31 11616836dpl:AdministrativeExpenses2025-11-01 2026-10-31 11616836dpl:DistributionCosts2025-11-01 2026-10-31116168362024-11-01 116168362025-10-31 116168362024-11-01 2025-10-31 11616836core:WithinOneYear2025-10-31 11616836core:AfterOneYear2025-10-31 11616836core:CurrentFinancialInstruments2025-10-31 11616836core:Non-currentFinancialInstruments2025-10-31 11616836core:LandBuildings2025-10-31 11616836core:PlantMachinery2025-10-31 11616836core:Vehicles2025-10-31 11616836core:FurnitureFittings2025-10-31 11616836core:OfficeEquipment2025-10-31 11616836core:OtherPropertyPlantEquipment2025-10-31 11616836core:Right-of-useAssets2025-10-31 11616836core:Goodwill2025-10-31 11616836core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-10-31 11616836core:PatentsTrademarksLicencesConcessionsSimilar2025-10-31 11616836core:OtherResidualIntangibleAssets2025-10-31 11616836dpl:AdministrativeExpenses2024-11-01 2025-10-3111616836bus:Director12025-11-01 2026-10-3111616836bus:PrivateLimitedCompanyLtd2025-11-01 2026-10-31
Ameira Therapies Ltd
Unaudited Financial Statements
for the year ended 31 October 2026
Company registration number 11616836
(England and Wales)

Company Information

For the year ended 31 October 2026
Director Eshiet, Imaobong

Registered office 84 Prior Deram Walk
Coventry
CV4 8FS

Registered number 11616836

Statement of Financial Position

As at 31 October 2026
2026
2025
£
£
£
£
Fixed assets
(1,391)
135
Current assets
8,960
(6,233)
Creditors amounts falling due within one year
(1,938)
4,774
Net current assets (liabilities)
7,022
(1,459)
Total assets less current liabilities
5,631
(1,324)
Creditors amounts falling due after one year
-
(5,365)
Net assets (liabilities)
5,631
(6,689)
Capital and reserves
5,631
(6,689)

Notes to the Financial Statements

1. Employees

The average number of employees during the year was 1 (2025: 0).
The company is a private company limited by shares and registered in England and Wales. It was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and authorised for issue by the director on 1 November 2026 and are signed on its behalf by:

Eshiet, Imaobong
Eshiet, Imaobong
Director

Company registration number 11616836